Advancing Precision Oncology with New Tumor Organoids

Patient-derived tumor organoids are emerging as high-fidelity preclinical models for precision oncology, offering a way to test cancer treatments on three-dimensional cell clusters that mirror a patient’s specific disease. Recent research led by investigators at Weill Cornell Medicine demonstrates that these “avatars” can reliably predict treatment sensitivity, potentially expanding the pool of patients eligible for … Read more

Unlocking the Role of the Immune System in Oral Precancerous Lesions

Breakthrough in Oral Cancer Research: New Immune Pathway Could Revolutionize Early Intervention Researchers at The University of Texas MD Anderson Cancer Center have uncovered a critical immune pathway linked to the progression of oral precancerous lesions into head and neck squamous cell carcinoma, offering a potential roadmap for early intervention. The findings, published in *Cancer … Read more

New Therapy Harnesses Cells’ Waste Removal to Target Multiple Myeloma

Researchers at VCU Massey Comprehensive Cancer Center have developed an experimental molecule called an autophagy-targeting chimera (AUTAC) that dismantles the MCL1 survival protein to kill multiple myeloma cells. According to a study published in Cell Death & Disease, this targeted protein degrader works with existing proteasome inhibitors to reduce cancer cell viability by 50% within … Read more

BCG Vaccine May Alter Human Brain Immunity

The Bacillus Calmette-Guérin (BCG) vaccine, typically used to prevent tuberculosis, may remodel the brain’s immune environment to potentially lower Alzheimer’s disease risk, according to research published in Communications Medicine. A year-long study led by Mass General Brigham investigators found the vaccine increased immune cell responsiveness and altered Alzheimer’s-related biomarkers in older adults without pre-existing pathology. … Read more

Prime-and-Pull Vaccine Effectively Prevents Genital Herpes

Researchers at the Yale School of Medicine have developed a two-part vaccination strategy that successfully prevented genital herpes infection in preclinical models. Published June 19 in Science Immunology, the study uses “prime and pull” technology—an initial intramuscular injection combined with localized nanoparticle delivery—to trigger a robust immune response at the vaginal lining, a feat traditional … Read more

New Geroscience Initiative to Accelerate Anti-Aging Therapies

The Albert Einstein College of Medicine has launched the Batia and Idan Ofer program for Validation of Interventions Targeting Aging and Longevity (BIO-VITAL), a specialized initiative designed to accelerate the development of pharmaceutical therapies that address the biological mechanisms of aging. By providing biotechnology firms access to proprietary research models and human longevity data, the … Read more

New Topical Gel Uses Repurposed MS Drug to Heal Burns

Beyond Skin Grafts: The New Era of Regenerative Wound Care For decades, the gold standard for treating severe burns has remained largely unchanged: skin grafting. While life-saving, this invasive procedure often leads to donor site morbidity, scarring, and long, painful recovery periods. However, a breakthrough from the Terasaki Institute for Biomedical Innovation is signaling a … Read more

Cytokine-armored CAR-T cell therapy successfully attacks aggressive brain tumors in mice

Beyond Blood Cancers: The New Frontier of Solid Tumor Therapy For years, CAR-T cell therapy has been hailed as a miracle for certain blood cancers, but solid tumors—particularly aggressive brain cancers like glioblastoma—have remained stubbornly resistant. The challenge isn’t just the cancer itself, but the “shield” these tumors build around themselves to hide from the … Read more

Next-generation cancer therapy shows early promise as treatment candidate for glioblastoma

Breaking the Deadlock: The New Frontier in Glioblastoma Treatment For more than twenty years, the standard of care for glioblastoma—the most common and aggressive primary brain cancer in adults—has remained largely stagnant. Despite the combined efforts of surgery, radiation, and chemotherapy, this disease remains uniformly fatal, often recurring rapidly after treatment. However, recent preclinical research … Read more

New hybrid molecule uses Trojan horse approach to treat obesity

Hybrid Molecule Shows Promise in Obesity and Type 2 Diabetes Treatment Researchers at Helmholtz Munich have unveiled a novel approach to tackling obesity and type 2 diabetes, utilizing a “Trojan horse” molecule that combines the benefits of existing incretin therapies with a targeted metabolic modulator. The preclinical study, published in Nature, demonstrates significant weight loss … Read more